ES2282705T3 - Uso de derivados de acido hidroxamico para la preparacion de medicamentos antitumorales. - Google Patents

Uso de derivados de acido hidroxamico para la preparacion de medicamentos antitumorales. Download PDF

Info

Publication number
ES2282705T3
ES2282705T3 ES03782390T ES03782390T ES2282705T3 ES 2282705 T3 ES2282705 T3 ES 2282705T3 ES 03782390 T ES03782390 T ES 03782390T ES 03782390 T ES03782390 T ES 03782390T ES 2282705 T3 ES2282705 T3 ES 2282705T3
Authority
ES
Spain
Prior art keywords
preparation
cells
tumor
itf
hydroxamic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03782390T
Other languages
English (en)
Spanish (es)
Inventor
Flavio Leoni
Paolo Mascagni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Application granted granted Critical
Publication of ES2282705T3 publication Critical patent/ES2282705T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES03782390T 2003-01-17 2003-12-10 Uso de derivados de acido hidroxamico para la preparacion de medicamentos antitumorales. Expired - Lifetime ES2282705T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000064A ITMI20030064A1 (it) 2003-01-17 2003-01-17 Uso dei derivati dell'acido idrossamico per la preparazione
ITMI03A0064 2003-01-17

Publications (1)

Publication Number Publication Date
ES2282705T3 true ES2282705T3 (es) 2007-10-16

Family

ID=32750476

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03782390T Expired - Lifetime ES2282705T3 (es) 2003-01-17 2003-12-10 Uso de derivados de acido hidroxamico para la preparacion de medicamentos antitumorales.

Country Status (8)

Country Link
US (1) US8227515B2 (https=)
EP (1) EP1583523B1 (https=)
JP (1) JP4495599B2 (https=)
AU (1) AU2003290034A1 (https=)
DE (1) DE60311888T2 (https=)
ES (1) ES2282705T3 (https=)
IT (1) ITMI20030064A1 (https=)
WO (1) WO2004064824A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1392908B1 (it) * 2008-09-29 2012-04-02 Italfarmaco Spa Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
KR20020070285A (ko) * 1999-11-23 2002-09-05 메틸진, 인크. 히스톤 디아세틸라제의 억제제
JPWO2002074298A1 (ja) * 2001-03-21 2004-07-08 小野薬品工業株式会社 Ｉｌ−６産生阻害剤
SE0101257D0 (sv) * 2001-04-06 2001-04-06 A & Science Invest Ab Treatment of whiplash associated disorder
ITMI20011733A1 (it) 2001-08-07 2003-02-07 Italfarmaco Spa Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc
JPWO2003070691A1 (ja) * 2002-02-21 2005-06-09 財団法人大阪産業振興機構 Ｎ−ヒドロキシカルボキサミド誘導体

Also Published As

Publication number Publication date
DE60311888D1 (de) 2007-03-29
EP1583523B1 (en) 2007-02-14
EP1583523A1 (en) 2005-10-12
AU2003290034A1 (en) 2004-08-13
US20060063800A1 (en) 2006-03-23
DE60311888T2 (de) 2007-12-06
JP2006514659A (ja) 2006-05-11
WO2004064824A1 (en) 2004-08-05
JP4495599B2 (ja) 2010-07-07
US8227515B2 (en) 2012-07-24
ITMI20030064A1 (it) 2004-07-18

Similar Documents

Publication Publication Date Title
JP7449913B2 (ja) オキサチアジン様化合物を作製する方法
JP7274450B2 (ja) 癌を処置するための医薬組合せ
ES2273688T3 (es) Procedimiento y composicion para el tratamiento de cancer.
ES2741901T3 (es) Compuestos antitumorales
ES2367028T3 (es) Composiciones sinérgicas con fk-228.
JP2001519366A (ja) ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法
US7951780B2 (en) Antitumor agent
AU2002237884B2 (en) Anticancer treatment using triptolide prodrugs
US6362207B1 (en) Methods of treating viral infections with benzimidazoles
AU2002237884A1 (en) Anticancer treatment using triptolide prodrugs
HUP0100853A2 (hu) Fekély kezelésére alkalmas nitrátsók és ilyen vegyületeket tartalmazó gyógyászati készítmények
WO1989007441A1 (en) 6-amino-1,2-benzopyrone antitumorigenic agents and method
ES2282705T3 (es) Uso de derivados de acido hidroxamico para la preparacion de medicamentos antitumorales.
CN107737124A (zh) 一种姜黄素类似物在制备抗肿瘤药物中的应用
US20190231793A1 (en) Use of harringtonines in the treatment of breast cancer, in particular triple-negative breast cancer
KR101345533B1 (ko) 신규 아다만탄계 화합물 또는 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 다약제내성 억제용 약학적 조성물
EP3441067A1 (en) Anti-tumor cocktail comprising an anti-tumor agent selective for tumor acidity, an antioxidant, and a p-glycoprotein inhibitor
US20030187046A1 (en) Pharmaceutical composition for inhibiting the growth of viruses and cancers
CN108498518A (zh) 七元环小檗碱类似物及其药物组合物在制备治疗血液肿瘤的药物中的应用
WO1994008584A1 (fr) Inhibiteur de la metastase d'une tumeur maligne
KR101167601B1 (ko) 항종양제
CN110698491A (zh) 2-（喜树碱-10-氧基）乙酰胺类化合物和应用
US20210163420A1 (en) Novel Spiro and Cyclic Bis-Benzylidine Proteasome Inhibitor for the Treatment of Cancer, Diabetes and Neurological Disorders
BR102014024940A2 (pt) Antitumoral coquette comprehending an selectional antitumor agent for tumor acidity, an antioxidant and an inhibitor of glycoprotein p
EP4271667A1 (en) Rad51 binding inhibitors and methods of use thereof